Long-term antioxidant administration attenuates mineralocorticoid hypertension and renal inflammatory response.
about
Effects of tempol and redox-cycling nitroxides in models of oxidative stress.Nitric oxide and peroxynitrite in health and diseaseChemistry and antihypertensive effects of tempol and other nitroxidesMaintenance of hypertensive hemodynamics does not depend on ROS in established experimental chronic kidney diseaseCrosstalk between the unfolded protein response and NF-κB-mediated inflammation in the progression of chronic kidney diseaseRenal autoregulation in health and diseaseAggravated renal inflammatory responses in TRPV1 gene knockout mice subjected to DOCA-salt hypertension.TNF-alpha inhibition reduces renal injury in DOCA-salt hypertensive rats.Dietary approach to attenuate oxidative stress, hypertension, and inflammation in the cardiovascular system.Upregulation of Nox1 in vascular smooth muscle leads to impaired endothelium-dependent relaxation via eNOS uncoupling.Superoxide dismutases: role in redox signaling, vascular function, and diseases.Depletion of endogenous kallistatin exacerbates renal and cardiovascular oxidative stress, inflammation, and organ remodeling.Vascular oxidative stress: the common link in hypertensive and diabetic vascular disease.Physiological and pathophysiological roles of oxygen radicals in the renal microvasculature.Reactive oxygen species: roles in blood pressure and kidney function.Apocynin prevents vascular effects caused by chronic exposure to low concentrations of mercuryCentral interactions of aldosterone and angiotensin II in aldosterone- and angiotensin II-induced hypertension.Infiltrating T lymphocytes in the kidney increase oxidative stress and participate in the development of hypertension and renal diseaseAndrogen-dependent hypertension is mediated by 20-hydroxy-5,8,11,14-eicosatetraenoic acid-induced vascular dysfunction: role of inhibitor of kappaB Kinase.Novel role of kallistatin in vascular repair by promoting mobility, viability, and function of endothelial progenitor cells.Inhibition of the tonic contraction in the treatment of erectile dysfunction.Renal inflammation, autoimmunity and salt-sensitive hypertension.Vascular NAD(P)H oxidases: specific features, expression, and regulation.Pyrrolidine dithiocarbamate down-regulates vascular matrix metalloproteinases and ameliorates vascular dysfunction and remodelling in renovascular hypertension.Reversal of cardiac dysfunction by selective ET-A receptor antagonism.Renal and vascular oxidative stress and salt-sensitivity of arterial pressure.Oxidative stress, renal infiltration of immune cells, and salt-sensitive hypertension: all for one and one for all.Aldosterone-induced inflammation in the rat heart : role of oxidative stress.α-Lipoic acid reduces neurogenic hypertension by blunting oxidative stress-mediated increase in ADAM17.Oxidative stress and cardiovascular disease: antioxidants and unresolved issues.Inflammasome activity is essential for one kidney/deoxycorticosterone acetate/salt-induced hypertension in mice.Mechanisms of disease: oxidative stress and inflammation in the pathogenesis of hypertension.Mitochondrial dysfunction causing cardiac sodium channel downregulation in cardiomyopathyNitric oxide and superoxide interactions in the kidney and their implication in the development of salt-sensitive hypertension.Intermedin ameliorates vascular and renal injury by inhibition of oxidative stressThe antioxidant tempol attenuates pressure overload-induced cardiac hypertrophy and contractile dysfunction in mice fed a high-fructose diet.NADPH oxidase contributes to renal damage and dysfunction in Dahl salt-sensitive hypertension.Synergistic actions of enalapril and tempol during chronic angiotensin II-induced hypertension.Intrarenal Angiotensin ii is associated with inflammation, renal damage and dysfunction in dahl salt-sensitive hypertension.The renin angiotensin aldosterone system in hypertension: roles of insulin resistance and oxidative stress.
P2860
Q24595411-8BD76847-2E17-48EE-BE03-70B9DAE6A991Q24645400-0F3B60C6-853A-4A5A-92E4-616EB45354B5Q24658069-9BB66123-27E9-4947-AD88-06EFA5C21B30Q27322607-81995B3E-7D0D-4E10-97A8-094D473B60F3Q28080433-3E7DCC2F-8E05-4595-AB83-6D453FDD1997Q28082365-B74AA416-BBA0-4F56-AEB0-9003786D0489Q33570102-B16CB4E5-AB20-4A43-A7CF-61F559F42DC4Q33647618-EB8430C2-CC87-446D-B96E-7B43E91D812CQ33782711-5D48E2C3-2567-46FD-A7EB-C0FD278CA406Q34150616-BACE456E-86DA-4437-AB34-B565B98363E9Q34176532-75990351-8266-4172-B7C1-7885946378B0Q34289034-B6D03CFB-DE30-48AC-B4EC-C9004E5B7EF0Q34479731-53A8AC93-5FEC-4247-85C0-4CEAB06EB94AQ34495243-F9A4C811-3A07-43C7-86A2-1B9BE8036CD0Q34555173-4486A567-A07D-4848-A68A-E5222B3FC470Q34580152-DB20D5EC-63FA-49C2-ADEE-FB4E6FD01334Q34600299-FC868BE6-50DC-4C36-9EA3-60902FDEC209Q34719254-A26A5BB8-028E-4BAE-8A43-13944739C7A8Q34780122-83DB1766-5754-42B7-BBD6-7E0EB565F6D7Q35070827-8780E878-8E7C-4E42-B128-0442FD3ABB99Q35095163-D8603869-1F7F-4CD5-9444-D6E4F855726CQ35109115-4C64CC99-9EF9-4A10-ABCE-B7114AD86A67Q35175526-392FDFFD-C838-4118-A8DA-343437E7B681Q35216484-D8289577-7500-431C-AA6B-0EBAF336BE8BQ35545108-89344365-948A-4183-A20C-9D5BF6AEC40FQ35583117-FFC4B1C7-DA6F-4C90-BA62-BB438A058167Q35682855-676F139E-51D8-463C-ACDB-C14345DDB586Q35747797-44250410-150F-4265-BD01-1208B84DB632Q36114331-F0FCAEDF-3BFC-49F6-86D2-EAE12211C2A5Q36188700-C8EA8A1C-8A54-4489-835B-0411AE7ACC72Q36546979-5C6A8019-8F3B-41E2-A7EA-6F947E0303D7Q36604954-96408946-5428-4228-8813-089AEAD33F89Q36678600-5A4F8614-706E-46A5-982C-0E1DEF041785Q36889247-D482959B-CE06-4AE9-AB23-97C5A5A3DC87Q37018402-0B3494B5-70A3-492A-884A-AFFAA5E15061Q37038754-17B6E937-0065-404E-8C2B-8BEC0A71ACB9Q37200072-49AB4F0E-AEF3-44DF-940F-584EAD88DF95Q37352389-907519AF-C7FB-4BD9-9F31-69AE063FA2F8Q37405031-F07C73D2-A5B8-4384-B5DD-3AB95EC483FEQ37475546-FC3F0B24-CB03-426D-AE04-08D0921E0BD7
P2860
Long-term antioxidant administration attenuates mineralocorticoid hypertension and renal inflammatory response.
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Long-term antioxidant administ ...... d renal inflammatory response.
@ast
Long-term antioxidant administ ...... d renal inflammatory response.
@en
type
label
Long-term antioxidant administ ...... d renal inflammatory response.
@ast
Long-term antioxidant administ ...... d renal inflammatory response.
@en
prefLabel
Long-term antioxidant administ ...... d renal inflammatory response.
@ast
Long-term antioxidant administ ...... d renal inflammatory response.
@en
P2093
P356
P1433
P1476
Long-term antioxidant administ ...... d renal inflammatory response.
@en
P2093
P304
P356
10.1161/01.HYP.37.2.781
P407
P433
P577
2001-02-01T00:00:00Z